These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12670938)

  • 1. P-glycoprotein catalytic mechanism: studies of the ADP-vanadate inhibited state.
    Urbatsch IL; Tyndall GA; Tombline G; Senior AE
    J Biol Chem; 2003 Jun; 278(25):23171-9. PubMed ID: 12670938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionally similar vanadate-induced 8-azidoadenosine 5'-[alpha-(32)P]Diphosphate-trapped transition state intermediates of human P-glycoprotin are generated in the absence and presence of ATP hydrolysis.
    Sauna ZE; Smith MM; Muller M; Ambudkar SV
    J Biol Chem; 2001 Jun; 276(24):21199-208. PubMed ID: 11287418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic validation of the models for P-glycoprotein ATP hydrolysis and vanadate-induced trapping. Proposal for additional steps.
    Lugo MR; Sharom FJ
    PLoS One; 2014; 9(6):e98804. PubMed ID: 24897122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in either nucleotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites.
    Urbatsch IL; Beaudet L; Carrier I; Gros P
    Biochemistry; 1998 Mar; 37(13):4592-602. PubMed ID: 9521779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanadate-induced trapping of nucleotides by purified maltose transport complex requires ATP hydrolysis.
    Sharma S; Davidson AL
    J Bacteriol; 2000 Dec; 182(23):6570-6. PubMed ID: 11073897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site.
    Urbatsch IL; Sankaran B; Weber J; Senior AE
    J Biol Chem; 1995 Aug; 270(33):19383-90. PubMed ID: 7642618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined mutation of catalytic glutamate residues in the two nucleotide binding domains of P-glycoprotein generates a conformation that binds ATP and ADP tightly.
    Tombline G; Bartholomew LA; Urbatsch IL; Senior AE
    J Biol Chem; 2004 Jul; 279(30):31212-20. PubMed ID: 15159388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the role of glutamine-471 and glutamine-1114 in the two catalytic sites of P-glycoprotein.
    Urbatsch IL; Gimi K; Wilke-Mounts S; Senior AE
    Biochemistry; 2000 Oct; 39(39):11921-7. PubMed ID: 11009605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between steady-state ATP hydrolysis and vanadate-induced ADP trapping in Human P-glycoprotein. Evidence for ADP release as the rate-limiting step in the catalytic cycle and its modulation by substrates.
    Kerr KM; Sauna ZE; Ambudkar SV
    J Biol Chem; 2001 Mar; 276(12):8657-64. PubMed ID: 11121420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of P-glycoprotein with mutations in the "catalytic carboxylate" glutamate residues.
    Tombline G; Bartholomew LA; Tyndall GA; Gimi K; Urbatsch IL; Senior AE
    J Biol Chem; 2004 Nov; 279(45):46518-26. PubMed ID: 15326176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric modulation bypasses the requirement for ATP hydrolysis in regenerating low affinity transition state conformation of human P-glycoprotein.
    Maki N; Moitra K; Ghosh P; Dey S
    J Biol Chem; 2006 Apr; 281(16):10769-77. PubMed ID: 16505485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity.
    Julien M; Gros P
    Biochemistry; 2000 Apr; 39(15):4559-68. PubMed ID: 10758006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy between conserved ABC signature Ser residues in P-glycoprotein catalysis.
    Tombline G; Bartholomew L; Gimi K; Tyndall GA; Senior AE
    J Biol Chem; 2004 Feb; 279(7):5363-73. PubMed ID: 14638679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the vectorial nature of drug (substrate)-stimulated ATP hydrolysis by human P-glycoprotein.
    Sauna ZE; Smith MM; Müller M; Ambudkar SV
    J Biol Chem; 2001 Sep; 276(36):33301-4. PubMed ID: 11451943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of conserved carboxylate residues in the nucleotide binding sites of P-glycoprotein.
    Urbatsch IL; Julien M; Carrier I; Rousseau ME; Cayrol R; Gros P
    Biochemistry; 2000 Nov; 39(46):14138-49. PubMed ID: 11087362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of catalytic carboxylate mutants E552Q and E1197Q suggests asymmetric ATP hydrolysis by the two nucleotide-binding domains of P-glycoprotein.
    Carrier I; Julien M; Gros P
    Biochemistry; 2003 Nov; 42(44):12875-85. PubMed ID: 14596601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of human P-glycoprotein ATPase activity. Photochemical cleavage during a catalytic transition state using orthovanadate reveals cross-talk between the two ATP sites.
    Hrycyna CA; Ramachandra M; Ambudkar SV; Ko YH; Pedersen PL; Pastan I; Gottesman MM
    J Biol Chem; 1998 Jul; 273(27):16631-4. PubMed ID: 9642211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
    Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH
    Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state.
    Ramachandra M; Ambudkar SV; Chen D; Hrycyna CA; Dey S; Gottesman MM; Pastan I
    Biochemistry; 1998 Apr; 37(14):5010-9. PubMed ID: 9538020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Coupling of Binding, ATP Hydrolysis, and Transport of Fluorescent Probes with P-Glycoprotein in Lipid Nanodiscs.
    Li MJ; Nath A; Atkins WM
    Biochemistry; 2017 May; 56(19):2506-2517. PubMed ID: 28441502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.